Thiambutosine

Thiambutosine

SCHEMBL1961184

CCCCOc1ccc(NC(=S)Nc2ccc(N(C)C)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 1.00
MAPT P10636 10/20 0.61
ALDH1A1 P00352 5/20 0.61
RAB9A P51151 3/20 0.61
KDM4E B2RXH2 2/20 0.61
MCL1 Q07820 2/20 0.61
TSHR P16473 1/20 0.61
HSD17B10 Q99714 1/20 0.61
SMN1; SMN2 Q16637 4/20 0.59
NPC1 O15118 2/20 0.59
HPGD P15428 2/20 0.59
MAPK1 P28482 2/20 0.59
GAA P10253 6/20 0.55
LMNA P02545 2/20 0.55
HRH3 Q9Y5N1 1/20 0.52
HTT P42858 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALOX12 P18054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1263730 0.82 PTGES (0.68) PTGESMAPTALDH1A1RAB9AKDM4E
SCHEMBL5451796 0.80 ALDH1A1 (0.70) PTGESMAPTALDH1A1RAB9AKDM4E
SCHEMBL25709829 0.79 PTGES (0.66) PTGESMAPTALDH1A1RAB9ASMN1; SMN2
Etocarlide SCHEMBL2439224 0.78 MAPT (0.89) PTGESMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL28999618 0.78 PTGES (0.63) PTGESMAPTMAPK1GAAL3MBTL1
SCHEMBL23302979 0.77 PTGES (0.62) PTGESMAPTALDH1A1RAB9AKDM4E
Etocarlide SCHEMBL359440 0.77 MAPT (0.96) PTGESMAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL1263398 0.77 PTGES (0.62) PTGESMAPTALDH1A1RAB9AKDM4E
SCHEMBL11001964 0.77 PTGES (0.62) PTGESMAPTALDH1A1RAB9AKDM4E
SCHEMBL11000930 0.77 PTGES (0.62) PTGESMAPTALDH1A1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106810469-B A kind of device and its production method of continuous production thiofide diphenylguanidine 山东尚舜化工有限公司 2019-09-24 CN claimed
CN-109304079-A The recyclable device and method of tail gas for rubber accelerator M 山东众瑞新材料科技有限公司 2019-02-05 CN claimed
CN-109256587-A Lithium metal secondary battery electrolyte and the lithium metal secondary battery for using the electrolyte 青海泰丰先行锂能科技有限公司 2019-01-22 CN claimed
CN-108641603-A A kind of polishing powder recovery process 永嘉立豪环保科技有限公司 2018-10-12 CN claimed
CN-107827781-A The production technology and equipments of continuous production diphenylguanidine 山东尚舜化工有限公司 2018-03-23 CN claimed
CN-206751706-U A kind of device of continuous production thiofide diphenylguanidine 山东尚舜化工有限公司 2017-12-15 CN claimed
CN-106810469-A The device and its production method of a kind of continuous production thiofide diphenylguanidine 山东尚舜化工有限公司 2017-06-09 CN claimed
CN-104024318-B Curable compositions based on the nitrile rubber containing epoxide group 朗盛德国有限责任公司 2016-10-26 CN claimed
CN-105916376-A Agrochemical composition 农作物智力有限公司 2016-08-31 CN claimed
CN-105348149-A Method for improving quality of diphenylguanidine product SHANDONG SUNSINE CHEMICAL CO LTD 2016-02-24 CN claimed
CN-203648513-U Automatic temperature control system for diphenylthiourea synthetic reaction TIANJIN YIHUA CHEMICAL CO LTD 2014-06-18 CN claimed
CN-103551256-A Activating agent for use in floatation of silver in zinc hydrometallurgy acid leaching pulp ZHUZHOU XIANGQI TECHNOLOGY DEV CO LTD 2014-02-05 CN claimed
CN-103556151-A Chemical milling solution and chemical milling method of gamma-titanium aluminum-based intermetallic compound INST METAL RES CHINESE ACAD SC 2014-02-05 CN claimed
CN-102426204-B Method for analyzing content of rubber accelerator thiocarbanilide KEMAI CHEMICAL CO LTD 2013-08-14 CN claimed
CN-102426204-A Method for analyzing content of rubber accelerator thiocarbanilide KEMAI CHEMICAL CO LTD 2012-04-25 CN claimed
US-20110142956-A1 USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS PEUKER HEIDEMARIE 2011-06-16 US claimed
US-20080051408-A1 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders SWITCH BIOTECH, LLC 2008-02-28 US claimed
EP-1759700-A1 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders Switch Biotech Aktiengesellschaft (DE) 2007-03-07 EP claimed
WO-2006018088-A1 USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS SWITCH BIOTECH AG (DE) 2006-02-23 WO claimed
WO-2004096222-A1 USE OF 1-(5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE, ITS ACTIVE METABOLITES, ISOMERS AND SALTS FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS SWITCH BIOTECH AG (DE) 2004-11-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110142956-A1 USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS PDE5A, PDE12, PDE2A PTGES 1933/4885MAPT 1589/4885ALDH1A1 342/4885
US-20080051408-A1 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders PDE5A, PDE2A, PDE3A PTGES 2538/4885MAPT 989/4885ALDH1A1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.